Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | SRC | P12931 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22817307 | 0.86 | ELANE (0.37) | ELANEALDH1A1MAPTHSP90AA1GAA | |
| SCHEMBL21010421 | 0.84 | ALDH1A1 (0.39) | ELANEALDH1A1MAPTHSP90AA1GAA | |
| SCHEMBL12901865 | 0.84 | LMNA (0.46) | ALDH1A1MAPTGAATSHRKMT2A | |
| SCHEMBL23733037 | 0.82 | ELANE (0.40) | ELANEALDH1A1MAPTHSP90AA1GAA | |
| SCHEMBL20306055 | 0.82 | TDP1 (0.36) | ALDH1A1MAPTGAATSHRKMT2A | |
| SCHEMBL19891675 | 0.81 | ELANE (0.36) | ELANEALDH1A1MAPTHSP90AA1GAA | |
| SCHEMBL19917249 | 0.78 | TGM2 (0.37) | TSHRATML3MBTL1TDP1SRC | |
| SCHEMBL22067559 | 0.77 | — | — | |
| SCHEMBL8288104 | 0.77 | ACHE (0.38) | ALDH1A1 | |
| SCHEMBL24217648 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11639338-B1 | Compound producing method, and compound | KUREHA CORPORATION (JP) | 2023-05-02 | — | — | US | disclosed |
| US-20230122812-A1 | COMPOUND PRODUCING METHOD, AND COMPOUND | KUREHA CORPORATION (JP) | 2023-04-20 | — | — | US | disclosed |
| US-20220195350-A1 | ANTI-MICROBIAL LIQUID DETERGENT COMPOSITION | THE PROCTER AND GAMBLE COMPANY | 2022-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11639338-B1 | Compound producing method, and compound | CA7, CYP3A7, GANC | ELANE 3303/4885ALDH1A1 1175/4885MAPT 3597/4885 |
| US-20230122812-A1 | COMPOUND PRODUCING METHOD, AND COMPOUND | CA7, CYP3A7, GANC | ELANE 3303/4885ALDH1A1 1175/4885MAPT 3597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.